A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutationMarta Castroviejo‐Bermejo, Violeta Serra, Mandy Ducy et al.|EMBO Molecular Medicine|2018Cited by 271
A CRISPR-Cas9 screen identifies EXO1 as a formaldehyde resistance geneYuandi Gao, Jean‐Yves Masson|Nature Communications|2023Cited by 26